Possible clinical outcome predictors for interlaminar ESI at short-term follow-upa
| Improvement (n = 63) | No Improvement (n = 18) | P Value | |
|---|---|---|---|
| Ageb | 50 ± 13.5 | 49.6 ± 17.6 | .914 |
| Sex | |||
| Male | 10 (62.5%) | 6 (37.5%) | .175 |
| Female | 53 (81.5%) | 12 (18.5%) | |
| Duration of LBP | |||
| <3 Months | 32 (78.0%) | 9 (22.0%) | 1.000 |
| >3 months | 31 (77.5%) | 9 (22.5%) |
a Data are number of patients.
b Mean age (years).